Foresite Capital Management IV as of June 30, 2020
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 12 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Keros Therapeutics (KROS) | 26.1 | $54M | 1.4M | 37.51 | |
| Cytokinetics (CYTK) | 18.5 | $38M | 1.6M | 23.57 | |
| Kura Oncology (KURA) | 10.4 | $21M | 1.3M | 16.30 | |
| Fulcrum Therapeutics (FULC) | 10.1 | $21M | 1.1M | 18.29 | |
| Vaxcyte (PCVX) | 9.6 | $20M | 621k | 31.61 | |
| Generation Bio (GBIO) | 8.8 | $18M | 858k | 21.00 | |
| Myokardia | 6.0 | $12M | 127k | 96.62 | |
| Cymabay Therapeutics | 4.8 | $9.9M | 2.8M | 3.49 | |
| Voyager Therapeutics (VYGR) | 3.2 | $6.5M | 517k | 12.62 | |
| Oric Pharmaceuticals (ORIC) | 2.1 | $4.2M | 125k | 33.73 | |
| Dicerna Pharmaceuticals | 0.3 | $635k | 25k | 25.40 | |
| Retrophin | 0.3 | $612k | 30k | 20.40 |
